| 摘要 |
Provided herein are methods of determining the tolerogenic potential of a therapeutic agent comprising determining the ability of the therapeutic agent to increase the expression of tolerogenic markers, e.g., PD-Ll, by antigen presenting cells such as monocytes, macrophages, B cells and dendritic cells. |
